Myomo, Inc. (MYO) Cash Flow Statement

The extreme variance in the OCF/NI ratio suggests that Myomo's cash generation is heavily influenced by the timing of insurance reimbursements rather than consistent operational performance. Investors should interpret this as a sign that reported net losses may not fully capture the underlying cash burn volatility inherent in the company's reimbursement-dependent business model.

The persistent FCF deficit suggests that the company is currently in a capital-intensive growth phase where the cost of patient acquisition and reimbursement navigation significantly outweighs the cash inflows from device sales. This trajectory warrants close monitoring, as the lack of a clear path to positive FCF suggests a continued reliance on external financing.

These swings indicate that Myomo's cash position is highly sensitive to the efficiency of its billing and collections department. The volatility in working capital suggests that management faces significant challenges in synchronizing the timing of device delivery with the receipt of cash from third-party payers.

While the absolute dollar amounts remain relatively small, the rising capital intensity indicates that the business is becoming more asset-heavy as it attempts to scale its operations. This trend may indicate that future growth will require sustained capital investment, further pressuring the company's already strained cash reserves.